Breast Cancer Clinical Trial
Official title:
Reducing the Burden of Breast Cancer Among African American and Latina Survivors
RATIONALE: Telephone sessions and survivorship booklets may increase knowledge about the
psychological and physical impact of breast cancer and increase awareness of available
resources. It is not yet known whether survivorship booklets are more effective when given
alone or together with individual telephone sessions in informing breast cancer survivors.
PURPOSE: This randomized clinical trial is studying individual telephone sessions given
together with survivorship booklets compared with survivorship booklets alone to see how
well they work in increasing knowledge about the impact of breast cancer in African American
and Latina breast cancer survivors.
OBJECTIVES:
Primary
- Evaluate the utility of individual telephone sessions plus survivorship booklets versus
the survivorship booklets alone in increasing knowledge about the psychological and
physical impact of breast cancer and increasing awareness of appropriate psychological
and medical resources among African American and Latina breast cancer survivors.
- Evaluate the utility of these interventions in improving psychological functioning
(depression and anxiety) among breast cancer survivors.
- Evaluate the utility of these interventions in improving family and social functioning
(changes in family and partner communications) among breast cancer survivors.
Secondary
- Evaluate predictors of health-related quality of life (demographic, medical care
factors, psychological, socio-ecological, and socio-cultural factors) within and across
breast cancer survivors ethnic groups to identify both general and ethnic-specific
correlates.
OUTLINE: Patients are stratified according to ethnicity (African American vs Latina).
Patients are randomized to 1 of 2 groups.
- Group 1: Patients receive a survivorship kit of booklets in English or Spanish.
Patients then receive a follow-up telephone call at approximately 2 months to clarify
any issues relevant to the survivorship kit of booklets.
- Group 2: Patients participate in 8 weekly telephone sessions addressing basic breast
cancer information; education about psychological and medical effects of cancer and its
treatments; resources including psychosocial, medical care facilities, and clinical
trials information; stress management and relaxation; cognitive reframing of concerns
and behavioral strategies; family communication; relational communication and intimacy;
and social support. Patients also receive a survivorship kit of booklets as in group 1.
After completion of study intervention, patients complete follow-up questionnaires at 4 to 6
months.
;
Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Open Label
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04681911 -
Inetetamab Combined With Pyrotinib and Chemotherapy in the Treatment of HER2 Positive Metastatic Breast Cancer
|
Phase 2 | |
Completed |
NCT04890327 -
Web-based Family History Tool
|
N/A | |
Terminated |
NCT04066790 -
Pyrotinib or Trastuzumab Plus Nab-paclitaxel as Neoadjuvant Therapy in HER2-positive Breast Cancer
|
Phase 2 | |
Completed |
NCT03591848 -
Pilot Study of a Web-based Decision Aid for Young Women With Breast Cancer, During the Proposal for Preservation of Fertility
|
N/A | |
Recruiting |
NCT03954197 -
Evaluation of Priming Before in Vitro Maturation for Fertility Preservation in Breast Cancer Patients
|
N/A | |
Terminated |
NCT02202746 -
A Study to Assess the Safety and Efficacy of the VEGFR-FGFR-PDGFR Inhibitor, Lucitanib, Given to Patients With Metastatic Breast Cancer
|
Phase 2 | |
Active, not recruiting |
NCT01472094 -
The Hurria Older PatiEnts (HOPE) With Breast Cancer Study
|
||
Completed |
NCT06049446 -
Combining CEM and Magnetic Seed Localization of Non-Palpable Breast Tumors
|
||
Withdrawn |
NCT06057636 -
Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study
|
N/A | |
Recruiting |
NCT05560334 -
A Single-Arm, Open, Exploratory Clinical Study of Pemigatinib in the Treatment of HER2-negative Advanced Breast Cancer Patients With FGFR Alterations
|
Phase 2 | |
Active, not recruiting |
NCT05501769 -
ARV-471 in Combination With Everolimus for the Treatment of Advanced or Metastatic ER+, HER2- Breast Cancer
|
Phase 1 | |
Recruiting |
NCT04631835 -
Phase I Study of the HS-10352 in Patients With Advanced Breast Cancer
|
Phase 1 | |
Completed |
NCT04307407 -
Exercise in Breast Cancer Survivors
|
N/A | |
Recruiting |
NCT03544762 -
Correlation of 16α-[18F]Fluoro-17β-estradiol PET Imaging With ESR1 Mutation
|
Phase 3 | |
Terminated |
NCT02482389 -
Study of Preoperative Boost Radiotherapy
|
N/A | |
Enrolling by invitation |
NCT00068003 -
Harvesting Cells for Experimental Cancer Treatments
|
||
Completed |
NCT00226967 -
Stress, Diurnal Cortisol, and Breast Cancer Survival
|
||
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06006390 -
CEA Targeting Chimeric Antigen Receptor T Lymphocytes (CAR-T) in the Treatment of CEA Positive Advanced Solid Tumors
|
Phase 1/Phase 2 |